Want to see AU:RHY full AI Analyst Report?
Total Valuation
Rhythm Biosciences Ltd. has a market cap or net worth of AU$35.31M. The enterprise value is AU$28.21.
Market CapAU$35.31M
Enterprise ValueAU$28.21
Share Statistics
Rhythm Biosciences Ltd. has 364,059,840 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding364,059,840
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Rhythm Biosciences Ltd.’s return on equity (ROE) is -1.63 and return on invested capital (ROIC) is -150.82%.
Return on Equity (ROE)-1.63
Return on Assets (ROA)-1.24
Return on Invested Capital (ROIC)-150.82%
Return on Capital Employed (ROCE)-2.00
Revenue Per Employee3.71K
Profits Per Employee-257.83K
Employee Count23
Asset Turnover0.02
Inventory Turnover275.00
Valuation Ratios
The current PE Ratio of Rhythm Biosciences Ltd. is ―. Rhythm Biosciences Ltd.’s PEG ratio is -0.21.
PE Ratio―
PS Ratio356.41
PB Ratio8.36
Price to Fair Value8.36
Price to FCF-5.78
Price to Operating Cash Flow-5.74
PEG Ratio-0.21
Income Statement
In the last 12 months, Rhythm Biosciences Ltd. had revenue of 85.34K and earned -5.93M in profits. Earnings per share was -0.02.
Revenue85.34K
Gross Profit-4.40M
Operating Income-7.46M
Pretax Income-7.51M
Net Income-5.93M
EBITDA-7.27M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -5.23M and capital expenditures -25.80K, giving a free cash flow of -5.26M billion.
Operating Cash Flow-5.23M
Free Cash Flow-5.26M
Free Cash Flow per Share-0.01
Dividends & Yields
Rhythm Biosciences Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.97
52-Week Price Change-4.40%
50-Day Moving Average0.09
200-Day Moving Average0.13
Relative Strength Index (RSI)49.38
Average Volume (3m)462.98K
Important Dates
Rhythm Biosciences Ltd. upcoming earnings date is Feb 24, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateFeb 24, 2027
Ex-Dividend Date―
Financial Position
Rhythm Biosciences Ltd. as a current ratio of 3.61, with Debt / Equity ratio of 6.82%
Current Ratio3.61
Quick Ratio3.59
Debt to Market Cap<0.01
Net Debt to EBITDA0.43
Interest Coverage Ratio-99.70
Taxes
In the past 12 months, Rhythm Biosciences Ltd. has paid -1.58M in taxes.
Income Tax-1.58M
Effective Tax Rate0.21
Enterprise Valuation
Rhythm Biosciences Ltd. EV to EBITDA ratio is -3.76, with an EV/FCF ratio of -5.19.
EV to Sales320.00
EV to EBITDA-3.76
EV to Free Cash Flow-5.19
EV to Operating Cash Flow-5.22
Balance Sheet
Rhythm Biosciences Ltd. has AU$3.44M in cash and marketable securities with AU$247.98K in debt, giving a net cash position of AU$3.19M billion.
Cash & Marketable SecuritiesAU$3.44M
Total DebtAU$247.98K
Net CashAU$3.19M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is -5151.30%, with operating margin of -8739.15%, and net profit margin of -6948.85%.
Gross Margin-5151.30%
Operating Margin-8739.15%
Pretax Margin-8795.48%
Net Profit Margin-6948.85%
EBITDA Margin-8517.35%
EBIT Margin-8739.15%
Analyst Forecast
The average price target for Rhythm Biosciences Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast239.64%
EPS Growth Forecast-37.21%